Frontline Maintenance in Ovarian Cancer

EP. 1: Molecular Testing and Ovarian Cancer

December 22nd 2021

Chad A. Hamilton, MD, and Robert W. Holloway, MD, discuss challenges clinicians face in treating ovarian cancer and review the current state of biomarker testing.

EP. 2: Sequencing of Biomarker Testing for Ovarian Cancer

January 20th 2022

Dr Robert W. Holloway explains his typical approach to ovarian cancer biomarker testing and sequencing.

EP. 3: Genetic Counseling for Ovarian Cancer

January 20th 2022

Oncologists debate the need for genetic counseling for ovarian cancer patients and how to approach molecular testing alongside neoadjuvant chemotherapy.

EP. 4: Case Scenario: Stage 3A High-Grade Epithelial Ovarian Cancer

January 27th 2022

Chad A. Hamilton, MD, and Robert W. Holloway, MD, review the case of a 57-year-old woman with stage IIIA high-grade epithelial ovarian cancer.

EP. 5: Starting Maintenance Therapy for Ovarian Cancer

January 27th 2022

Robert W. Holloway, MD, details how he decides to start maintenance therapy after first-line ovarian cancer treatments.

EP. 6: Ovarian Cancer: Significant Clinical Trials

February 3rd 2022

Dr. Chad Hamilton explains pivotal data from several important clinical trials in ovarian cancer.

EP. 7: Case Scenario: Stage 3C High-Grade Serous Ovarian Cancer

February 3rd 2022

Experts review the potential maintenance therapy approaches for a 64-year-old woman with stage IIIC high-grade serous ovarian cancer.

EP. 8: Ovarian Cancer Maintenance Therapy: Olaparib vs. Niraparib

February 10th 2022

Key opinion leaders discuss how they decide between two regimens for ovarian cancer maintenance therapies.

EP. 9: Ovarian Cancer Maintenance Therapy Clinical Pearls

February 10th 2022

Robert W. Holloway, MD, and Chad A. Hamilton, MD, provide clinical pearls for community physicians using maintenance therapies for ovarian cancer.

EP. 10: The Future of Ovarian Cancer Treatment

February 17th 2022

Oncologists contemplate what ovarian cancer treatment will look like in the future and exciting clinical trials in progress.